Physician profile
Mani Bashyam
NPI 1801993514
$11,920.68
in general payments reported to CMS, 2019-2025
56 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what 75% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,500 · 2020: $753 · 2021: $972 · 2022: $1,447 · 2023: $1,604 · 2024: $1,803 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,225 · Education: $24.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,224.97 |
| Education | $24.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,266.02 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $1,118.75 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $772.27 | 2019-2022 | |
| Amgen INC. | $755.17 | 2019-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $682.52 | 2019-2025 | |
| Dexcom, INC. | $640.99 | 2021-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $486.11 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Mannkind Corporation | $405.94 | 2020-2025 | Afrezza |
| Bayer Healthcare Pharmaceuticals INC. | $405.03 | 2022-2023 | |
| Insulet Corporation | $314.22 | 2019-2025 | Omnipod |
| Corcept Therapeutics | $307.73 | 2019-2025 | Korlym |
| Antares Pharma, INC. | $294.57 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Beta Bionics, INC. | $279.53 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.92 | 2019-2023 | Jardiance |
| Abbvie INC. | $248.71 | 2019-2024 | Synthroid |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $240.61 | 2019-2025 | Tymlos |
| Abbott Laboratories | $238.79 | 2019-2025 | Freestyle Libre 3 |
| Amneal Pharmaceuticals LLC | $232.72 | 2019-2025 | Unithroid |
| Tandem Diabetes Care, INC. | $230.32 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $203.49 | 2019-2022 | |
| Axonics, INC. | $190.61 | 2024 | Axonics |
| Becton, Dickinson and Company | $179.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $161.46 | 2019 | |
| Valeritas, INC. | $156.53 | 2019 | |
| Horizon Therapeutics Plc | $144.58 | 2022-2023 | Tepezza |
| Medtronic, INC. | $141.55 | 2021-2024 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Medtronic Minimed, INC. | $136.38 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $132.75 | 2019-2025 | Strensiq |
| Neurocrine Biosciences, INC. | $126.58 | 2024-2025 | |
| Amphastar Pharmaceuticals, INC. | $110.90 | 2024-2025 | |
| Sequel Med Tech, LLC | $110.47 | 2025 | Twiist |
| Amarin Pharma, INC. | $93.50 | 2019 | |
| Shire North American Group INC | $80.66 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $70.48 | 2019 | |
| Intuity Medical INC | $66.99 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Recordati_rare_diseases_inc. | $61.35 | 2023 | Isturisa, Signifor Lar |
| Zealand Pharma US, INC. | $54.89 | 2021 | |
| Vistapharm, INC. | $52.64 | 2021 | |
| Vivus LLC | $48.10 | 2019 | |
| Aytu Biopharma, INC. | $45.58 | 2019 | |
| Ascendis Pharma Endocrinology INC | $43.95 | 2025 | Yorvipath |
| Cequr Corporation | $42.56 | 2022-2025 | Cequr Simplicity |
| Nalpropion Pharmaceuticals LLC | $41.02 | 2019 | |
| Tolmar, INC. | $33.64 | 2023 | |
| Madrigal Pharmaceuticals | $24.52 | 2025 | Rezdiffra |
| Acella Pharmaceuticals, LLC | $24.48 | 2025 | NP Thyroid 60 |
| Genentech USA, INC. | $24.33 | 2020 | |
| Kyowa Kirin, INC. | $23.37 | 2024 | Crysvita |
| Companion Medical, INC. | $17.30 | 2019 | |
| Halozyme INC | $16.71 | 2023 | |
| Ascensia Diabetes Care US INC. | $16.71 | 2023 | |
| Althera Pharmaceuticals LLC | $15.30 | 2021 | |
| Lifescan, INC. | $14.90 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.23 | 2019 | |
| Sanofi Pasteur INC. | $13.86 | 2020 | |
| Pfizer INC. | $12.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mani Bashyam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.